A Study of Different Forms of BGB-43395 and Food Effect in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

January 14, 2025

Primary Completion Date

May 20, 2025

Study Completion Date

May 20, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

BGB-43395

Administered orally as solid dispersion tablet or salt tablet

DRUG

BGB-43395

Administered orally as solid dispersion tablet or salt tablet

Trial Locations (1)

32117-5116

Fortrea Cru, Daytone Beach, Daytona Beach

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BeiGene

INDUSTRY